echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > JASN: New urine test can be used to diagnose kidney transplant rejection

    JASN: New urine test can be used to diagnose kidney transplant rejection

    • Last Update: 2021-03-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    For patients who need a kidney transplant, the waiting time can take up to six years.
    Even if they receive a transplant, up to 20% of patients will experience rejection.
    Transplant rejection occurs when the recipient's immune cells recognize the newly received kidney as a foreign body and refuse to accept the donor's antigen.
    Current methods of testing for renal rejection include invasive biopsy procedures, which result in patients requiring hospitalization for several days.
    A study conducted by researchers at Brigham and Women’s Hospital and Exosome Diagnostics proposes a new non-invasive method that uses exosomes (microvesicles containing mRNA) in urine to test for transplant rejection.
    Their findings were published in the Journal of the American Society of Nephrology.

    "Our goal is to develop better tools to monitor patients without the need for unnecessary biopsies.
    We try to detect rejection as early as possible so that it can be treated before scars form," said Jamil, associate physician at the Brigham Kidney Transplant Department.
    Azzi said: "If rejection is not treated, it can lead to scarring and complete kidney failure.
    Because of these problems, recipients may face lifelong side effects.

    Before this study, when doctors suspected that the transplant recipient had rejected the donor organ, they ordered a biopsy or blood test.
    The biopsy procedure carries a risk of complications, and 70-80% of biopsy results are normal.
    In addition, blood tests for creatinine do not always give definitive results.
    Due to the limitations of current tests, researchers are looking for alternative and simpler methods to evaluate the effect of transplantation.

    In this study, researchers collected urine samples from 175 patients who had undergone a kidney biopsy recommended by a doctor.
    From these samples, the researchers isolated urine exosomes from the immune cells of the newly transplanted kidney.
    The researchers isolated proteins and mRNA from these vesicles, and determined the rejection signal (a set of 15 genes), which can distinguish whether rejection has occurred.
    It is worth noting that the researchers also identified five genes that can distinguish two types of rejection: cellular rejection and antibody-mediated rejection.

    "These findings suggest that exosomes isolated from urine samples may be viable biomarkers of kidney transplant rejection," Azzi said.

    This study is different from previous attempts to characterize urine mRNA because clinicians isolated exosomes instead of ordinary urine cells.
    Exosomal vesicles can protect mRNA from degradation, so that it is possible to check whether genes in mRNA have matching rejection characteristics.
    In previous studies, mRNA was isolated from cells shed into the urine from the kidneys.
    However, if there are no extracellular vesicles to protect the mRNA, the mRNA will be quickly degraded, which makes the test difficult to perform in a clinical setting.

    Azzi said: "Our research shows that if urine is obtained from patients at different time points and mRNA is measured from microvesicles, it shows that it will not disappear over time, so that it can accurately assess whether the transplant has been rejected.

    Information source: Novel urine test developed to diagnose human kidney transplant rejection

    Original source: Rania El Fekih et al, Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection, Journal of the American Society of Nephrology (2021).
    DOI: 10.

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.